- Original research
- Open Access
Ultra-wide-field retinal imaging in the management of non-infectious retinal vasculitis
© Leder et al.; licensee Springer. 2013
- Received: 11 September 2012
- Accepted: 12 September 2012
- Published: 11 February 2013
The purpose of this study is to describe and quantify the benefit of ultra-wide-field imaging and fluorescein angiography (FA) in the management of non-infectious retinal vasculitis. In this prospective observational cohort series, patients with non-infectious retinal vasculitis were evaluated and enrolled by four investigators from the Divisions of Retina and Ocular Immunology at the Wilmer Eye Institute. In each patient, disease activity and the need for management changes were assessed, based on clinical examination with or without standard (60°) imaging and then with the addition of ultra-wide-field pseudo-color scanning laser ophthalmoscope (SLO) images and FA using the Optos ultra-wide-field SLO (Optos Panoramic 200MA™, Optos PLC, Dunfermline, Scotland, UK). A standardized questionnaire was completed by each investigator at the time of the clinical evaluation.
The primary outcome was the percentage of patients whose management was changed by clinical examination and standard FA, compared with clinical examination plus ultra-wide-field imaging. The secondary outcome was the percentage of patients whose disease was determined to be active based on each modality.
Seventy-one visits from 23 patients were reviewed and analyzed. Based on examination plus ultra-wide-field imaging and ultra-wide-field angiography, disease activity was detected in 48/71 (68%) compared with 32/71 (45%) based on examination and standard FA (P = 0.0095). Based on the clinical examination alone, the decision to alter management was made in 4 of 71 visits (6%), and an additional 3 of 71 (4%) based on simulated standard FA. The addition of ultra-wide-field SLO pseudo-color images altered management in an additional 10/71 visits (14%), and 36/71 (51%) with the addition of ultra-wide-field FA.
Ultra-wide-field fluorescein imaging and angiography can provide additional information that may be important and relevant in the management of retinal vasculitis.
- Non-infectious retinal vasculitis
- Fluorescein angiography
- Ultra-wide-field imaging
Non-infectious retinal vasculitis is a challenging disease to treat. Treatment must be titrated to minimize side effects while preserving vision. Disease activity is monitored through a combination of patient symptoms, clinical examination (including slit lamp, indirect ophthalmoscopy, and direct contact lens biomicroscopy), and retinal imaging studies . Vascular leakage, an important element of retinal vasculitis, is best appreciated and detected with fluorescein angiography (FA). Conventional retinal photography, including FA, is limited in its field of view. Most fundus cameras can capture only 30° to 60° of the fundus at a time. While sweeps of the retina can be performed to sample larger areas of the retina, such an approach cannot image the entire retina simultaneously. The limited view makes it difficult to correctly locate peripheral lesions and to confirm/compare changes over time. The clinician is left relying on diagrams in clinic charts, standard photographs, and memory to assess disease progression.
There are several models of wide-field imaging devices. The Optos P200 (Optos PLC, Dunfermline, Scotland, UK) uses a scanning laser ophthalmoscope (SLO) to image 200° of the retina at a time. It is also capable of fluorescein angiography transiting the same 200° area. Such capabilities make it ideal for monitoring progressive peripheral retinal vascular diseases and may be helpful in the clinical management of posterior uveitis [2, 3].
Several case reports have found that ultra-wide-field imaging with FA is well tolerated by patients, can image through small pupils, and can significantly contribute to the management of retinal disease, though there can be a number of imaging artifacts that interfere with image interpretation . It can be useful in a wide variety of retinal vascular disorders including uveitis, cytomegalovirus retinitis, vein occlusions, diabetes, as well as non-vascular conditions such as retinal detachment, retinal tumors, and choroidal tumors. However, these publications are limited to retrospective case reports or series [4–15].
Kaines et al. reviewed five cases of posterior uveitis seen at their institution and identified several attributes of the SLO ultra-wide-field imaging system that aided in the diagnosis and management of their patients . They noted that the high-resolution images allowed clear documentation of peripheral retinal lesions and greatly eased longitudinal comparisons for disease activity and progression. Areas of neovascularization and non-perfusion were easily identified, aiding targeted pan-retinal photocoagulation. In several patients, they also noted peripheral angiographic findings that suggested disease activity in the absence of clinical evidence of the disease.
The index study employed the use of ultra-wide-field imaging modality prospectively in the management of patients with non-infectious retinal vasculitis to determine whether the added information provided by the ultra-wide-field images would alter management compared with standard examination and standard (60°) imaging.
Seventy-one visits of 23 consented patients were analyzed in this prospective observational case series. All patients had ultra-wide-field imaging following their clinical examination. Associated diagnoses of the 23 patients prior to enrollment into the study included the following: 6 with panuveitis, 3 with biopsy-proven sarcoidosis, 3 with intermediate uveitis, 2 with Adamantiades-Behcet’s disease, 1 with Wegener’s disease, and 8 with no associated syndrome (idiopathic).
Percentage of patients who demonstrated disease activity and whether management was changed based on examination and imaging
Disease activity (n = 71) (%)
Change in management (n = 71) (%)
0.0006a and 0.0095b
<0.0001a and <0.0001b
In the index, prospective, observational study of patients with non-infectious vasculitis, the first, to our knowledge, to evaluate systematically and prospectively the role of ultra-wide-field imaging in retinal vasculitis, our results suggest that ultra-wide-field imaging may alter management decisions compared to standard-of-care imaging and clinical examination. Such differences are likely due to the ability to image the peripheral retinal and angiographic findings that are not easily visualized or identified without ultra-wide-field imaging. Both the determination of disease ‘activity’ and disease management differed significantly with the use of ultra-wide-field imaging compared with standard imaging. Management decisions were significantly altered, suggesting that qualitative and quantitative differences in the degree of disease activity seen on ultra-wide-field imaging may play an important role.
Our study was designed to investigate the potentials of wide-angle imaging in making management decisions in patients with non-infectious vasculitis, but not to determine the specific changes in patient management. Therefore, we did not obtain data on the management decisions that were made. Future investigations are needed to evaluate the degree of alteration (i.e., changing the dose of prednisone, addition of immunomodulatory therapy) associated with the additional information provided by the wide-angle imaging system and whether such alterations have led to additional benefits to the patients.
There are limitations to our study. The examining clinicians were not masked to 60°, as would have been ideal. Given the demands of clinical care and for practical and ethical reasons, we were unable to perform both the standard FA and the ultra-wide-field FA at the same visit. Thus, to determine disease activity and management based on examination and ‘conventional’ (30° or 60°) FA, investigators were asked to limit their assessment to the central 30° or 60° (based on preference) of the ultra-wide-field images (simulated conventional FA). Simulated peripheral sweeps were permitted if the investigator indicated that based on their clinical examination, peripheral sweeps were needed. The clinicians had to restrict themselves to the central image to evaluate the patient before considering the entire image. We attempted to limit bias by prospectively evaluating the ultra-wide-field imaging and acquiring the activity and management data based on the clinical examination prior to sending the patient for imaging, though the possibility of investigators biasing their responses to the standard FA question cannot be excluded with our study design.
In addition, it is also possible that there is selection bias in this study population towards the investigators selecting patients who may be more likely to have peripheral retinal findings that would change management, and not be representative of all patients with retinal vasculitis. Future studies may choose to enroll all patients with posterior uveitis consecutively to eliminate this potential bias.
In addition, ‘retinal vasculitis’ is a difficult entity to define. The Standardization of Uveitis Nomenclature Working Group  was unable to agree on a definition of vasculitis. We defined vasculitis as a retinal vascular occlusion, with leakage on fluorescein, overlying vitritis, vascular sheathing, and retinal hemorrhages in the context of ophthalmic inflammation. The definition of retinal vasculitis remains an area of debate, and different clinicians may define vasculitis using different criteria.
The index study was not designed to determine the utility of FA (standard or ultra-wide-field) in patients who do not appear to have active disease, though we did note a number of patients who demonstrated evidence of disease activity on peripheral angiography and who clinically appeared to have quiescent disease. The clinical significance of this ‘additionally noted’ disease activity is unknown since ultra-wide-field imaging modality has not previously been used in clinical practice or clinical trials.
Our study represents the first attempt to investigate prospectively the use of ultra-wide-field imaging and angiography in patients with non-infectious retinal vasculitis. The findings from our study suggest that the additional information provided by ultra-wide-field imaging may allow earlier detection of active vasculitis, which may lead to earlier treatment and perhaps better patient outcomes. Ultra-wide-field imaging altered management decisions compared to standard-of-care imaging and/or clinical examination of patients with retinal vasculitis. The decision to alter management may be due to the ability of such systems to detect disease activity in the periphery, such as angiographic findings, not easily visualized or identified with examination or standard imaging alone. Additional longitudinal studies with larger patient populations are required to determine the utility and application of ultra-wide-field imaging in the management of patients with retinal vasculitis. It is possible that such studies will demonstrate improved patient outcomes with clinical management based on findings detected on ultra-wide-field photography and angiography.
The primary outcome was the percentage of patients whose management was changed by clinical exam and standard FA, compared with examination plus ultra-wide-field imaging. The secondary outcome was the percentage of patients whose disease was determined to be active with each modality. The primary and secondary outcome measures were analyzed in terms of proportions (i.e., proportion of patients who were determined to be active based on ultra-wide-field imaging compared with examination and standard FA) using the pretest function in Stata v11.0 (College Station, TX, USA).
The Institutional Review Board approval was obtained from the Johns Hopkins University School of Medicine before the study enrolled any patients. Written, informed consent was obtained from all patients included in this study. The research adhered to the tenets of the Declaration of Helsinki and was in accordance with all local, state, and federal regulations, including HIPAA.
The study is supported in part by the Uveitis Research Fund at the Wilmer Eye Institute. The Johns Hopkins University has received research aid in the form of instrument support from Optos, Inc. No direct financial support was received for this research.
The research was presented in part as a paper presentation at the 2011 Meeting of the Association for Research in Vision and Ophthalmology (Fort Lauderdale, FL, USA) and at the 2011 Meeting of the American Academy of Ophthalmology (Orlando, FL, USA).
- Jabs DA, Nussenblatt RB, Rosenbaum JT, Standardization of Uveitis Nomenclature (SUN) Working Group: Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. Am J Ophthalmol 2005, 140: 509–516.PubMedView ArticleGoogle Scholar
- Manivannan A, Plskova J, Farrow A, Mckay S, Sharp PF, Forrester JV: Ultra-wide field fluorescein angiography of the ocular fundus. Am J Ophthalmol 2005, 140: 525–527. 10.1016/j.ajo.2005.02.055PubMedView ArticleGoogle Scholar
- Kaines A, Tsui I, Sarraf D, Schwartz S: The use of ultra wide field fluorescein angiography in evaluation and management of uveitis. Semin Ophthalmol 2009, 24: 19–24. 10.1080/08820530802520095PubMedView ArticleGoogle Scholar
- Anderson L, Friberg TR, Singh J: Ultrawide-angle retinal imaging and retinal detachment. Semin Ophthalmol 2007, 22: 43–47. 10.1080/08820530601162867PubMedView ArticleGoogle Scholar
- Coffee RE, Jain A, McCannel TA: Ultra wide field imaging of choroidal metastasis secondary to primary breast cancer. Semin Ophthalmol 2009, 24: 34–36. 10.1080/08820530802520194PubMedView ArticleGoogle Scholar
- Jain A, Shah SP, Tsui I, McCannel TA: The value of Optos Panoramic 200MA imaging for the monitoring of large suspicious choroidal lesions. Semin Ophthalmol 2009, 24: 43–44. 10.1080/08820530802520384PubMedView ArticleGoogle Scholar
- Kernt M, Pinter F, Hadi I, Hirneiss C, Haritoglou C, Kampik A, Ulbig MW, Neubauer AS: Diabetic retinopathy: comparison of the diagnostic features of ultra-widefield scanning laser ophthalmoscopy Optomap with ETDRS 7-field fundus photography. Ophthalmologe 2011, 108: 117–123. 10.1007/s00347-010-2226-4PubMedView ArticleGoogle Scholar
- Kernt M, Schaller UC, Stumpf C, Ulbig MW, Kampik A, Neubauer AS: Choroidal pigmented lesions imaged by ultra-wide field scanning laser ophthalmoscopy with two laser wavelengths (Optomap). Clin Ophthalmol 2010, 4: 829–836.PubMed CentralPubMedView ArticleGoogle Scholar
- Khandhadia S, Madhusudhana KC, Kostakou A, Forrester JV, Newsom RS: Use of Optomap for retinal screening within an eye casualty setting. Br J Ophthalmol 2009, 93: 52–55. 10.1136/bjo.2008.148072PubMedView ArticleGoogle Scholar
- Mackenzie PJ, Russell M, Ma PE, Isbister CM, Maberley DA: Sensitivity and specificity of the Optos Optomap for detecting peripheral retinal lesions. Retina 2007, 27: 1119–1124. 10.1097/IAE.0b013e3180592b5cPubMedView ArticleGoogle Scholar
- Meyer CH, Saxena S: Non-mydriatic imaging of a giant retinal tear with the Optos Optomap Panoramic 200MA. Clin Experiment Ophthalmol 2010, 38: 427. 10.1111/j.1442-9071.2010.02260.xPubMedView ArticleGoogle Scholar
- Mudvari SS, Virasch VV, Singa RM, MacCumber MW: Ultra-wide field imaging for cytomegalovirus retinitis. Ophthalmic Surg Lasers Imaging 2010, 41: 311–315. 10.3928/15428877-20100430-03PubMedView ArticleGoogle Scholar
- Prasad PS, Oliver SC, Coffee RE, Hubschman JP, Schwartz SD: Ultra wide field angiographic characteristics of branch retinal and hemicentral retinal vein occlusion. Ophthalmology 2010, 117: 780–784. 10.1016/j.ophtha.2009.09.019PubMedView ArticleGoogle Scholar
- Shah SP, Jain A, Tsui I, McCannel TA: Optos Optomap Panoramic 200MA imaging of a serous choroidal detachment responsive to furosemide. Semin Ophthalmol 2009, 24: 40–42. 10.1080/08820530802520236PubMedView ArticleGoogle Scholar
- Spaide RF: Peripheral areas of nonperfusion in treated central retinal vein occlusion as imaged by wide-field fluorescein angiography. Retina 2011,31(5):829–837. 10.1097/IAE.0b013e31820c841ePubMedView ArticleGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.